Introduction {#dex087s11}
============

Although adiponectin was once thought to be exclusively secreted from adipose tissue, it is now known that adiponectin and its receptors, adiponectin receptor 1 (AdipoR1) and 2 (AdipoR2), are expressed in multiple tissues, such as liver, skeletal muscle, placenta and in mammalian preimplantation embryos ([@dex087C13]; [@dex087C6]; [@dex087C23]; reviewed by [@dex087C10]). This peptide hormone is involved in the regulation of glucose metabolism and fatty acid break down in adult organisms. It has been shown that adiponectin lowers intracellular lipid content in two ways. One way is by regulating circulating levels of insulin/insulin-like growth factor (IGF) and facilitating insulin/IGF sensitivity and action, thereby regulating fatty acid oxidation indirectly via the insulin/IGF-system ([@dex087C12]; [@dex087C18]).

The other way is direct stimulation of fatty acid oxidation and a reduction of fatty acid synthesis (for review see, [@dex087C700]). Adiponectin regulates lipid metabolism primarily by phosphorylation and thus activation of 5′-AMP-activated protein kinase (AMPK) ([@dex087C44]). AMPK increases fatty acid oxidation in skeletal muscle by regulating acetyl-CoA carboxylase (ACC) through phosphorylation and thereby stimulating carnitine palmityl transferase 1 (CPT1), the key enzyme of β-oxidation ([@dex087C7]). Adiponectin influences peroxisome proliferator-activated receptor α (PPARα), key regulator of fatty acid metabolism controlling CPT1 and hormone-senstive lipase (HSL) expression ([@dex087C37]; [@dex087C48]; [@dex087C31]).

The adaptor protein (APPL1) is the 'missing link' in the adiponectin signalling cascade, transmitting signals from both adiponectin receptors, AdipoR1 and AdipoR2, to downstream targets ([@dex087C25]). APPL1 is required for adiponectin-induced activation of AMPK and p38 mitogen-activated protein kinases (p38 MAPK) activation, which acts as an essential mediator in regulation of glucose uptake and fatty acid oxidation ([@dex087C25]).

In adults, adiponectin serum concentration is inversely associated with adipocyte mass. Maternal obesity elevates foetal adiponectin levels above the normal level and leads to increased foetal adipose tissue mass ([@dex087C30]). Diseases associated with abnormal adiponectin levels are pregestational diabetes, polycystic ovary syndrome and endometriosis, all of which are associated with subfertility ([@dex087C21]; [@dex087C8]; [@dex087C9]).

Whereas the role of adiponectin in modulation of lipid metabolism and insulin responsiveness in adult tissues is well established, its role in regulating lipid utilization and insulin sensitivity in preimplantation embryos is largely unknown. Adiponectin and its receptors are expressed in rabbit and mouse preimplantation embryos and influences mammalian embryo development and glucose metabolism (reviewed by [@dex087C10]).

In previous studies, we have shown that the rabbit blastocyst is not able to produce insulin ([@dex087C17]) and that it compensates for the maternal insulin deficiency by upregulation of IGF1 and IGF2 synthesis ([@dex087C41]). Furthermore, we have demonstrated that an experimentally induced maternal diabetes mellitus type 1 in rabbits correlates with an increased level of adiponectin in maternal serum and uterine tissue. This increase was accompanied by a strong increase in lipid vesicles in blastocysts ([@dex087C34], [@dex087C35]). Mammalian preimplantation embryos, i.e. human, bovine, mouse, pig and rabbit, contain lipid droplets in various amounts (reviewed by [@dex087C40]). The stored lipids serve as an energy source and influence cell--cell interactions, cell proliferation and intracellular transport mechanisms (for review see [@dex087C39]). However, excess lipid accumulation above the normal level is linked with impaired embryo quality due to cellular dysfunction and/or cell death caused by increased lipid peroxidation and mitochondrial dysfunction ([@dex087C1]; [@dex087C22]). In the current study, we have focused on the potential role of adiponectin in embryonic lipid metabolism, to clarify whether maternal diabetes during early pregnancy affects the embryonic lipid metabolism via adiponectin.

Materials and Methods {#dex087s12}
=====================

Embryo recovery {#dex087s12a}
---------------

Embryos were collected from sexually mature rabbits (outbred ZIKA-hybrid New Zealand White), stimulated with 110 IU pregnant mare\'s serum gonadotropin s.c. (Intervet, Germany) 3 days before mating. After mating, 75 IU hCG had been injected i.v. (Intervet, Germany) to ensure ovulation. Mating and embryo recovery were performed as described previously ([@dex087C34]). For *in vivo* and *in vitro* analysis, gastrulation stages 1 and 2 were used.

For RNA isolation, blastocysts were washed three times in phosphate-buffered saline (PBS) containing 0.05% polyvinyl alcohol (PVA). The extracellular coverings were removed mechanically and samples were stored in PBS at −80°C until RNA isolation.

For western blot analysis, blastocysts were washed 3 times in PBS and the extracellular coverings were removed mechanically in 0.05% PVA/PBS containing protease and phosphatase inhibitors (Roche, Germany). Samples were stored in radioimmunoprecipitation assay buffer with protease and phosphatase inhibitors at −80°C until further processing.

Embryo *in vitro* culture {#dex087s12b}
-------------------------

To study the effects of adiponectin on the expression of adiponectin signalling molecules \[APPL1, AMPK, ACC, p38 MAPK, lipogenic molecules (PPARα, CPT1, cluster of differentiation 36 (CD36), fatty acid transport protein 4 (FATP4), fatty acid binding protein 4 (FABP4), HSL and lipoprotein lipase (LPL)) and the insulin/IGF-system (IGF1, IGF2, IGF receptor (IGF1R) and insulin receptor (InsR))\], day 6 blastocysts were cultured in groups of three to five at 37°C in a water saturated atmosphere of 5% O~2~, 5% CO~2~, 90% N~2~ for one or 4 h with 1 μg/ml adiponectin (Biovendor, Germany) for RNA analysis. Control embryos were cultured without adiponectin. To prove AMPK-dependency, blastocysts were pre-cultured with Compound C, a specific AMPK inhibitor (10 μM, Sigma Germany) dissolved in dimethylsulfoxid (DMSO) for 30 min and subsequently cultured with 1 μg/ml adiponectin for 1 h. A DMSO group was included as solvent control for Compound C. For protein analysis, blastocysts were cultured with 1 μg/ml adiponectin for 15 min or 4 h in groups of six to nine. Incubation periods of adiponectin for protein and RNA analysis are based on our pervious study ([@dex087C17]) and the literature ([@dex087C48]). After culture, blastocysts were processed as describe above and stored at −80°C.

Alloxan treatment {#dex087s12c}
-----------------

Experimental insulin-dependent diabetes (diabetic) was induced in mature 18--20-week-old female rabbits by alloxan (Sigma-Aldrich, Germany) treatment 10--12 days before mating, as described ([@dex087C17]). Surgery was performed under Ketanest (Pfizer, Germany) and Dorbene (Zoetis, Germany) anaesthesia. Rabbits were held in a diabetic condition with permanent blood glucose concentrations of \>14 mmol/l by regular insulin supplementation three times per day (Huminsulin basal (NPH), Lilly Deutschland GmbH, Germany), starting on the second day after alloxan treatment. The blood glucose level was monitored as described previously ([@dex087C35]) and routinely measured during the whole experiment and at the time of death ([Supplementary Table S1](#sup2){ref-type="supplementary-material"}). Insulin and adiponectin levels have been measured and published previously and are summarized in [Supplementary Table S1](#sup2){ref-type="supplementary-material"}. All animal experiments were performed in accordance with the principles of laboratory animal care and the experimental protocol had been approved by the local ethics committee (Landesverwaltungsamt Dessau; reference number: 42502-2-812).

RNA isolation and cDNA synthesis {#dex087s12d}
--------------------------------

Messenger RNA of single blastocysts was extracted with Dynabeads^®^ Oligo (dT)~25~ (Invitrogen, Germany) and subsequently used for cDNA synthesis. All procedures were carried out according to the manufacturer\'s instructions, but with modifications described previously ([@dex087C35]). The final volume of cDNA reaction was adjusted with water to 100 μl.

Real time PCR analyses {#dex087s12e}
----------------------

Real time quantitative PCR analyses (RT-qPCR) were performed in duplicate using the Applied Biosystems StepOnePlus™ System (Applied Biosystems, Germany) with a no-template control for each primer set with SYBR Green detection. The nucleotide sequences of the primers used are listed in [Supplementary Table SII](#sup3){ref-type="supplementary-material"}. The PCR products were sequenced and analyzed as described ([@dex087C34]). GAPDH, which is unaffected by the treatment ([@dex087C41]), was simultaneously quantified as endogenous control and target gene expression was normalized to that of GAPDH in each sample. In each RT-qPCR, a calibration curve was included from serial dilutions (10^7^−10^3^ copies) of primer-specific DNA plasmid standards. Results were calculated as amounts of target RNA in molecules per molecule GAPDH RNA, and expressed as relative amounts as a percentage or fold change of control samples.

Protein preparation and immunoblotting {#dex087s12f}
--------------------------------------

Protein preparation, quantification and western blot were performed with 8--10 blastocysts as described ([@dex087C34]). For detection of CPT1, activating transcription factor 2 (ATF2), p38 MAPK and β-Actin, membranes were blocked in Tris-buffered saline containing 0.1% Tween with 3% (wt/vol) nonfat dry milk at room temperature for at least 1 h. For phosphorylated ACC (pACC), ACC2, phosphorylated AMPK (pAMPK), AMPK and PPARα detection, membranes were blocked in Tris-buffered saline containing 0.1% Tween with 3% (wt/vol) bovine serum albumin for at least 1 h. The primary antibody was incubated at 4°C overnight. The antibodies used are summarized in [Supplementary Table SIII](#sup4){ref-type="supplementary-material"}. Protein amount was calculated as the ratio of band intensities (pACC, ACC2, p38 MAPK, AMPK, ATF2 and CPT1 protein versus β-actin protein, and pAMPK protein versus AMPK protein (pAMPK/AMPK), respectively) in the same blot to correct for differences in protein loading.

Statistics {#dex087s12g}
----------

Data are expressed as mean ± SEM. The levels of significance between groups were calculated using Student\'s *t*-test after proving normal distribution. Multiple comparisons were made by factorial variance analysis (ANOVA) adjusted according to Bonferroni (SigmaPlot v. 12.0, Germany). Statistical significance is indicated as follows \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001 or by different letters in Figs [2](#dex087F2){ref-type="fig"} and [4](#dex087F4){ref-type="fig"}A and B (*P* \< 0.05). All experiments were repeated at least three times.

Results {#dex087s13}
=======

AMPK signalling by adiponectin in rabbit preimplantation embryos *in vitro* {#dex087s13a}
---------------------------------------------------------------------------

In rabbit blastocysts adiponectin increased phosphorylation and total protein amount of AMPK (Fig. [1](#dex087F2){ref-type="fig"}A). Phosphorylation of ACC was elevated, whereas no significant changes were observed for ACC2 and p38 MAPK protein amounts after 4 h of adiponectin stimulation (Fig. [1](#dex087F2){ref-type="fig"}A). A short stimulus (15 min) increased ACC phosphorylation and reduced p38 MAPK amount, while ACC2 amount was not changed (Fig. [1](#dex087F2){ref-type="fig"}B).

![Relative amounts of phosphorylated acetyl-CoA carboxylase, p38 mitogen-activated protein kinase and acetyl-CoA carboxylase 2 protein in blastocysts cultured *in vitro* with 1 μg/ml adiponectin. (**A**) *In vitro* culture of blastocysts for 4 h with 1 μg/ml adiponectin led to significantly higher protein level of AMPK and carnitine palmityl transferase 1 (CPT1) compared to treatment control (set 100%) and are indicated with the dashed line (\**P* \< 0.05, Student\'s *t*-test). Furthermore, phosphorylation of AMPK (ratio pAMPK/AMPK) and ACC (pACC) were increased. No significant changes were observed for acetyl-CoA carboxylase 2 (ACC2), p38 mitogen-activated protein kinase (p38 MAPK) and activating transcription factor 2 (ATF2) compared to the treatment control (set 100%, indicated with \-\--). Culture of blastocysts was performed in groups of at least three blastocysts. Per sample three blastocysts were pooled. The number of samples used per treatment group in each independent experiment was at least 3 (*n* ≥ 3,) with *N* = 3 (number of individual and independent experimental replicates). Protein levels were analyzed by western blot and results are shown as mean ± SEM. A representative western blot is shown. (**B**) pACC, ACC2 and p38 MAPK protein expression was quantified in blastocysts cultured for 15 min with adiponectin by western blot and calculated in relation to β-actin (mean ± SEM, *N* = 3 (number of independent experiments), *n* ≥ 3 (number of samples used per treatment group in each independent experiment, per sample three blastocysts have been pooled)). Phosphorylation of ACC was increased, while no changes in amount of ACC2 protein was observed after 15 min incubation with adiponectin. Total p38 MAPK protein amount was significantly decreased by adiponectin (\**P* \< 0.05 Student\'s *t*-test).](dex087f01){#dex087F2}

Adiponectin-dependent expression of lipogenic genes in rabbit preimplantation embryos *in vitro* {#dex087s13b}
------------------------------------------------------------------------------------------------

After 1 h of stimulation with adiponectin, the quantification of PPARα, APPL1, CPT1 and CD36 transcripts revealed an increased expression of all markers in cultured blastocysts (Fig. [2](#dex087F3){ref-type="fig"}). A simultaneous incubation with Compound C, a specific AMPK inhibitor, blocked this effect completely. Surprisingly, Compound C blocked PPARα transcription compared to the solvent control DMSO indicating that, even without external stimuli in blastocysts, PPARα transcription is AMPK-dependent.

![Changes in mRNAs in blastocysts cultured *in vitro* with adiponectin and/or Compound C for 1 h. Quantitative RT-PCR (RT-qPCR) of peroxisome proliferator-activated receptor alpha (PPARα; **A**), adaptor protein (APPL1; **B**), cluster of differentiation 36 (CD36; **C**) and CPT1 (**D**) after *in vitro* culture (for 1 h) of blastocysts with 1 μg/ml adiponectin or without (control; set 100%) showed an increased expression pattern. Inhibition of AMPK by Compound C blocked the adiponectin mediated increased transcription. *In vitro* culture was performed in groups of at least four blastocysts in each treatment and repeated in three independent replicates (*N* = 3 (number of individual and independent experiments); *n* ≥ 4 (number of blastocysts used per treatment group in each independent experiment)). Results are shown as mean ± SEM and control was set 100%. Means with different letters are significantly different (*P* \< 0.05, Multiple comparisons by factorial variance analysis (ANOVA)).](dex087f02){#dex087F3}

After 4 h stimulation, expression of APPL1, PPARα, CD36, FATP4, FABP4 and CPT1 remained increased (Figs [1](#dex087F2){ref-type="fig"}A and [3](#dex087F4){ref-type="fig"}). Transcript levels of HSL were increased, whereas the expression of LPL was not affected (Fig. [3](#dex087F4){ref-type="fig"}), which closely reflects the regulation pattern observed *in vivo* (Table [I](#dex087TB4){ref-type="table"}). Table IAdiponectin target gene expression in blastocysts from non-diabetic and diabetic rabbits.GeneRNA amounts \[molecules/per 100 molecules GAPDH\]*P* valueNon-diabeticDiabeticAPPL115.57 \[1.22\]20.76 \[1.53\]0.030PPARa1.00 \[0.13\]1.39 \[0.16\]0.084CD360.54 \[0.07\]0.54 \[0.06\]0.965HSL0.40 \[0.09\]1.03 \[0.13\]0.004LPL2.15 \[0.34\]2.27 \[0.80\]0.906ATF20.86 \[0.13\]5.58 \[0.93\]0.002[^1]

![Relative amounts of adiponectin target genes in blastocysts stimulated *in vitro* with adiponectin for 4 h. Transcription analyses of adaptor protein (APPL1), peroxisome proliferator-activated receptor alpha (PPARα), CD36, fatty acid transporter 4 (FATP4), fatty acid binding protein 4 (FABP4), hormone sensitive lipase (HSL) and lipoprotein lipase (LPL) were performed by RT-qPCR in blastocysts cultured *in vitro* with adiponectin (1 μg/ml) for 4 h. Culture was performed in groups of at least 4 and repeated in three independent replicates (*N* = 3 (number of individual and independent experiments); *n* ≥ 4 (number of samples used per treatment group in each independent experiment, per sample four blastocysts have been pooled)). Values are expressed as fold change relative to the treatment control (set 100% and indicated with the dashed line) (\**P* \< 0.05, Student\'s *t*-test).](dex087f03){#dex087F4}

Adiponectin-dependent expression of the insulin/IGF-system in rabbit preimplantation embryos *in vitro* {#dex087s13c}
-------------------------------------------------------------------------------------------------------

Adiponectin stimulation of rabbit blastocysts for 1 h led to an increased expression of IGF1 (Fig. [4](#dex087F5){ref-type="fig"}A). This effect could be blocked by Compound C, indicating that adiponectin regulates IGF1 expression in an AMPK-dependent manner. IGF2 transcription was not significantly upregulated after adiponectin stimulation. However, AMPK inhibition by Compound C decreased IGF2 mRNA amount, indicating an AMPK-dependent transcription (Fig. [4](#dex087F5){ref-type="fig"}B). Messenger RNA amounts of IGF1R and InsR (Fig. [4](#dex087F5){ref-type="fig"}C, D) were elevated in blastocyst cultured with adiponectin. These data demonstrate a clear insulin/IGF/adiponectin interaction with an increased insulin and IGF sensitivity due to adiponectin.

![Transcription of insulin/insulin-like growth factor system in blastocysts cultured *in vitro* with adiponectin. (**A**) Analysis of insulin-like growth factor 1 (IGF1) mRNA amounts by RT-qPCR revealed an increased expression in blastocysts after *in vitro* culture with 1 μg/ml adiponectin or without \[control, set 100%\] after 1 h incubation. Inhibition of AMPK by Compound C blocked adiponectin mediated increased mRNA. (**B**) *In vitro* culture with 1 μg/ml adiponectin did not significantly influence insulin-like growth factor 2 (IGF2) mRNA level after 1 h incubation compared to treatment control \[control, set 100%\]. However, co-culture with Compound C reduces IGF2 mRNA compared to the solvent control, DMSO. *In vitro* culture was performed in groups of at least four blastocysts in each treatment and repeated in three independent replicates (*N* = 3 (number of individual and independent experiments); *n* ≥ 4 (number of blastocysts used per treatment group in each independent experiment)). Results are shown as mean ± SEM. Means with different letters are significantly different (*P* \< 0.05, Multiple comparisons by factorial variance analysis (ANOVA)). In blastocysts cultured for 4 h with adiponectin mRNA levels of IGF1 receptor (IGF1R; **C**) and insulin receptor (InsR; **D**) were significantly increased compared to control, which was set 100% (\**P* \< 0.05, Student\'s *t*-test). *In vitro* culture was performed in groups of at least four blastocysts in each treatment and repeated in three independent replicates (*N* = 3 (number of individual and independent experiments); *n* ≥ 4 (number of samples used per treatment group in each independent experiment)). Results are shown as mean ± SEM.](dex087f04){#dex087F5}

Adiponectin signalling in preimplantation embryos from diabetic rabbits {#dex087s13d}
-----------------------------------------------------------------------

In blastocysts from diabetic rabbits, the phosphorylation of AMPK was significantly higher than in non-diabetic (ND) rabbits (Fig. [5](#dex087F6){ref-type="fig"}A). The total AMPK protein amount was not affected (Fig. [5](#dex087F6){ref-type="fig"}B). Phosphorylation of ACC was significantly increased in blastocysts from diabetic rabbits (Fig. [5](#dex087F6){ref-type="fig"}C). No significant changes of the ACC2 protein amount were observed (Fig. [5](#dex087F6){ref-type="fig"}D). Protein amount of p38 MAPK was upregulated under diabetic developmental conditions (Fig. [5](#dex087F6){ref-type="fig"}E). Protein (Fig. [5](#dex087F6){ref-type="fig"}F) and mRNA (Table [I](#dex087TB4){ref-type="table"}) of ATF2, essential for p38 MAPK-mediated suppression of lipid deposition, were significantly increased in blastocysts from diabetic rabbits.

![Western blot and densitometric quantification of proteins in blastocysts from diabetic rabbits. Phosphorylation and protein levels of phospho-AMPK (**A**), AMPK (**B**), phospho-ACC (**C**), ACC2 (**D**), p38 MAPK (**E**), ATF2 (**F**), PPARα (**G**) and CPT1 (**H**) were quantified in 6 day old blastocysts from diabetic \[D\] and non-diabetic rabbits \[ND\]. Rabbits were made diabetic before pregnancy. For all analyzed proteins a representative western blot is shown. The western blot is representative of more than three independent experiments with similar results (*N* ≥ 3 (number of individual and independent experiments), *n* ≥ 4 (number of samples used per treatment group in each independent experiment, per sample eight blastocysts have been pooled)). The relative amounts are shown in diagrams after normalization for the levels of β-actin. Values are expressed as mean ± SEM in % of non-diabetic controls (\**P* \< 0.05, \*\**P* \< 0.01, Student\'s *t*-test).](dex087f05){#dex087F6}

Expression of lipogenic signal molecules in the preimplantation embryo from diabetic rabbits {#dex087s13e}
--------------------------------------------------------------------------------------------

Transcription of PPARα was slightly elevated in blastocysts from diabetic rabbits (Table [I](#dex087TB4){ref-type="table"}). Western blot analysis showed a significantly higher protein amount of PPARα (Fig. [5](#dex087F6){ref-type="fig"}G). The protein expression of CPT1 was increased in blastocysts from diabetic rabbits (Fig. [5](#dex087F6){ref-type="fig"}H, [Supplementary Fig. S1](#sup1){ref-type="supplementary-material"}). Transcription of CD36 and LPL was not changed under diabetic developmental conditions in blastocysts, whereas the mRNA amount of HSL was increased (Table [I](#dex087TB4){ref-type="table"}).

Discussion {#dex087s14}
==========

Adiponectin plays an important role in regulation of cellular lipid metabolism and systemic adipose deposits. Adiponectin levels were found to be closely related to the level of insulin. Whereas a maternal diabetes mellitus type 2 is associated with a decreased adiponectin level, type 1 diabetes led to an increase in adiponectin level ([@dex087C21]; [@dex087C38]). In the diabetic rabbit model, adiponectin levels were increased in serum (3.7-fold) and the endometrium (2.2-fold) ([@dex087C34]). However, in the Fallopian and uterine secretions adiponectin amounts are still unknown because of the small sample volumes and resulting methodical limitations. Two main signalling pathways of adiponectin regulating lipid metabolism are known: the direct AMPK- and/or p38 MAPK-dependent activation of fatty acid uptake and β-oxidation, and the indirect way via the insulin/IGF-system ([@dex087C48]). In the current study, we found that both metabolic pathways are activated due to hyperadiponectinaemia (summarized in Fig. [6](#dex087F7){ref-type="fig"}) with profound consequences for early development: a strong stimulation of lipid metabolism in a vulnerable stage of embryo development.

![Model for adiponectin signalling in rabbit blastocysts stimulated *in vitro* with adiponectin. After binding of adiponectin to its receptors, AMPK is activated via APPL1. AMPK regulates β-oxidation by ACC phosphorylation, leading to an increased protein amount of CPT1. Furthermore, adiponectin increases PPARα expression and thereby regulating fatty acid uptake. However, the amount of p38 MAPK, a downstream target of APPL1, was decreased in blastocysts cultured *in vitro* with adiponectin. Besides its ability to regulate embryonic lipid metabolism directly, adiponectin increases paracrine amount of IGFs and InsR and IGF1R transcription in rabbit blastocysts via AMPK, which may indirectly influence embryonic lipid metabolism (![](dex087u02.jpg) Direct activation, ![](dex087u03.jpg) Direct inhibition, ![](dex087u04.jpg) Indirect regulation, = no change, ![](dex087u05.jpg) increase).](dex087f06){#dex087F7}

Adiponectin signalling starts with ligand binding to AdipoRs. In blastocysts from diabetic rabbits only AdipoR1 is upregulated ([@dex087C34]). We have already shown that adiponectin stimulation (for 15 min) *in vitro* led to an increased activation of AMPK in rabbit blastocysts ([@dex087C17]). Here, we show that AMPK phosphorylation is also elevated in blastocysts from diabetic rabbits. From mouse knockout studies, it is known that AdipoR1 is more involved in the activation of AMPK by adiponectin than AdipoR2 ([@dex087C46]). The increased activation of AMPK correlates well with the upregulation of AdipoR1 expression in blastocysts from diabetic rabbits and is strong experimental evidence that blastocysts from diabetic mothers are more sensitive to adiponectin.

In contrast to mice studies ([@dex087C46]), we have shown an AMPK-dependent PPARα expression. PPARα regulates promotor activity of lipogenic genes in mice, such as CD36, a fatty acid transporter, sterol regulating binding protein 1 (SREBP1) and CPT1 ([@dex087C3]). In blastocysts from diabetic rabbits SREBP1 activity is increased ([@dex087C35]). In the present study, CPT1 expression was adiponectin-dependently upregulated. The increased CPT1 amount in blastocysts from diabetic rabbits indicates that embryonic metabolism is shifted towards a metabolism gaining energy from β-oxidation of fatty acids. The importance of β-oxidation has been proven in bovine and mice studies. By using a specific inhibitor for CPT1, it has been shown in mice that β-oxidation is essential for oocyte maturation, zygote cleavage and blastocyst development ([@dex087C16]; [@dex087C15]; [@dex087C28]). In mouse adipocytes adiponectin suppresses lipolysis via AdipoR1 by altering activation of HSL ([@dex087C29]). Both adiponectin stimulation *in vitro* and an increased adiponectin level *in vivo* led to an increased transcription of HSL and may contribute to the increased accumulation of intracellular lipids in rabbit blastocysts ([@dex087C35]).

The other signalling pathway by which adiponectin may alter directly embryonic lipid metabolism is via p38 MAPK. p38 MAPK regulates fatty acid and glucose metabolism in response to adiponectin ([@dex087C45]; [@dex087C2]). To our surprise *in vitro* stimulation with adiponectin led to a decreased amount of p38 MAPK. p38 MAPK signalling is required to promote development to the blastocysts stage in mice by regulating glucose consumption, increasing apoptosis and disrupting tight junction integrity ([@dex087C4]; [@dex087C36]). However, in blastocysts from diabetic rabbits phosphorylation of p38 MAPK was increased. For suppression of lipid deposition by p38 MAPK, the activation of ATF2 is necessary ([@dex087C47]). In blastocysts from diabetic rabbits ATF2 transcription was increased, supporting our findings of an increased expression of p38 MAPK. No significant changes of ATF2 expression were observed after adiponectin supplementation *in vitro*, which is in accordance with the observed decreased amount of p38 MAPK. Therefore, we can conclude that under *in vivo* conditions a ligand other than adiponectin is responsible for activating the p38 MAPK/ATF2 pathway.

Activation of p38 MAPK has been observed in relation to inflammatory response, oxygen tension and oxygen radical metabolites (reviewed by [@dex087C27]). Since diabetic pregnancies are associated with inflammation and oxygen radical metabolites (reviewed by [@dex087C49]), it is tempting to speculate that both factors are responsible for the observed increased amount of p38 MAPK. Furthermore, excess lipid accumulation in non-adipose tissue leads to cell dysfunction caused by an increased lipid peroxidation and mitochondrial dysfunction. This observation is known as lipotoxicity (for review see [@dex087C5]). The lipotoxity may contribute to the observed increased apoptosis rate, higher embryo loss and developmental delay in diabetic and/or obese animals ([@dex087C24]; [@dex087C42]; [@dex087C14]). Facts supporting that the 'lipotoxicity hypothesis' in embryos is also applicable for the diabetic model, is the increased apoptosis and higher expression of ATF4, an endoplasmic stress marker, in blastocysts from diabetic rabbits ([@dex087C17]; [@dex087C35]).

Adiponectin influences fatty metabolism also indirectly via the insulin/IGF-system. In rabbit preimplantation embryos insulin is not expressed, but its family members IGF1 and IGF2 and both receptors, InsR and IGF1R, are ([@dex087C17]). It was shown that blastocysts compensate for the maternal insulin deficiency by upregulation of IGFs synthesis ([@dex087C41]). Interestingly, not only IGF1 and IGF2, but also IGF1R and InsR are upregulated after incubation with adiponectin in non-diabetic blastocysts. These results imply an increased insulin/IGFs availability and sensitivity, due to an increased receptor expression in response to adiponectin, which is already known from adult tissues ([@dex087C12]; [@dex087C18]).

Taken together, we show that adiponectin regulates embryonic lipid metabolism by AMPK signalling (Fig. [6](#dex087F7){ref-type="fig"}). Adiponectin directly influences fatty acid utilization, by regulating lipolysis, fatty acid transport and β-oxidation. In our model of an experimentally induced diabetes mellitus type 1, the preimplantation embryo switches its metabolism towards a fatty acid-dependent energy metabolism, which is mediated by the adiponectin/adipoR1/AMPK network. Contrary to cell models ([@dex087C48]; [@dex087C43]), adiponectin does not directly increase the amount of p38 MAPK in embryos, indicating a divergent adiponectin pathway in adult tissues and embryonic cells. Furthermore, we propose and show another potential mechanism: the simultaneous stimulation of insulin/IGF-system by adiponectin. The current study shows that preimplantation embryos are able to adapt to changes in the surrounding milieu and that adiponectin is an important mediator in this adaptation process.
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[^1]: RNA target genes amounts were quantified by RT-PCR in 10 to 15 blastocysts in each group. Values are expressed per 100 molecules GAPDH \[mean value ± SEM\]. The levels of significance between groups were calculated using Student\'s *t*-test after confirming a normal distribution. APPL1, adaptor protein 1; PPARa, peroxisome proliferator-activated receptor alpha; CD36, cluster of differentiation 36; HSL, hormone sensitive lipase; LPL, lipoprotein lipase; ATF2, activating transcription factor 2.
